BCX logo

Bioceltix (BCX)

Share price (7-session average)
66.80 PLN-9.56% w/w
Market cap
PLN 449.2M
52-week range
57.50 – 99.00 PLN

Prices as of November 20, 2026, delayed.

Last updated: Source: ESEF / ESPI / GPW

Compiled by: Zespół redakcyjny WszystkieAkcje.pl · Market data teamMethodology

Price Chart

Chart byTradingView

About Bioceltix

Bioceltix is a biotechnology company developing biological drugs based on stem cells for animals. Main projects focus on treating dogs and horses.

This description was generated with the help of AI and may contain inaccuracies. Please verify important information from official sources.

Company Details

Company Name
BIOCELTIX SPÓŁKA AKCYJNA
Ticker
BCX
ISIN
PLBCLTX00019
Listed Since
November 1, 2021
Shares Issued
5.53M
CEO
Łukasz Bzdzion
FIGI
BBG013DQ9F61
Registered AddressUL.BIERUTOWSKA 57-59. BUD. III 51-317 WROCŁAW

Data sourced from GPW and OpenFIGI. Updated periodically — verify with official sources.

News

All company filings →

Communities

Frequently asked questions

How much does a Bioceltix share cost?
The 7-day average share price of Bioceltix (BCX) on GPW is 66.80 PLN.
On which exchange is Bioceltix listed?
Bioceltix is listed on GPW under the ticker BCX, ISIN: PLBCLTX00019.
Is Bioceltix stock being shorted?
Per the KNF short-selling register (as of November 22, 2026), there are no disclosed net short positions in Bioceltix. KNF discloses positions from 0.5% of share capital, so smaller ones are not visible.

Similar companies — Biotechnology

Explore the market

Embed on your site

This information is provided for informational purposes only and does not constitute investment advice or a recommendation. Listings describe companies by the stated criteria and are not an inducement to buy or sell any financial instrument. Verify figures against official sources before making any investment decision.

Methodology & data sources